Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Acorda Therapeutics
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of CP
No previous use of any dalfampridine formulation
Ability to perform all the required study procedures. Subjects should be capable of fully extending and flexing both hands
You may not be if
Presence of any progressive neurological disease
Severe CP defined as the requirement to use a wheelchair at all times and a care taker for constant assistance in daily activities. This definition includes spastic quadriplegia
